Acquiring identified the palmitoylation motif of APLNR, we built a brief substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This aggressive peptide, which targets the APLNR palmitoylation web-site in combination with morphine, can inhibit the event of NCP, like pain incidence, microglial activation, and inflammatory aspect release https://conolidine-1-the-original55319.webdesign96.com/27374778/getting-my-block-pain-receptors-with-proleviate-to-work